Literature DB >> 34109619

A myriad of roles of dendritic cells in atherosclerosis.

Yanfang Zhao1, Jing Zhang2, Wenjie Zhang1, Yuekang Xu1.   

Abstract

Atherosclerosis is an inflammatory disease with break-down of homeostatic immune regulation of vascular tissues. As a critical initiator of host immunity, dendritic cells (DCs) have also been identified in the aorta of healthy individuals and atherosclerotic patients, whose roles in regulating arterial inflammation aroused great interest. Accumulating evidence has now pointed to the fundamental roles for DCs in every developmental stage of atherosclerosis due to their myriad of functions in immunity and tolerance induction, ranging from lipid uptake, efferocytosis and antigen presentation to pro- and anti-inflammatory cytokine or chemokine secretion. In this study we provide a timely summary of the published works in this field, and comprehensively discuss both the direct and indirect roles of DCs in atherogenesis. Understanding the pathogenic roles of DCs during the development of atherosclerosis in vascular tissues would certainly help to open therapeutic avenue to the treatment of cardiovascular diseases.
© 2021 British Society for Immunology.

Entities:  

Keywords:  T cells; atherosclerosis; cytokines; dendritic cells

Mesh:

Year:  2021        PMID: 34109619      PMCID: PMC8446417          DOI: 10.1111/cei.13634

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  135 in total

1.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 2.  Regulation and Immune Function of IL-27.

Authors:  Qinghong Wang; Jianguo Liu
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

3.  Monocytes and dendritic cells are the primary sources of interleukin 37 in human immune cells.

Authors:  Ina Rudloff; Steven X Cho; Jason C Lao; Devi Ngo; Matthew McKenzie; Claudia A Nold-Petry; Marcel F Nold
Journal:  J Leukoc Biol       Date:  2016-11-23       Impact factor: 4.962

4.  Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.

Authors:  Emmanouil Kyriakakis; Marco Cavallari; Jan Andert; Maria Philippova; Christoph Koella; Valery Bochkov; Paul Erne; S Brian Wilson; Lucia Mori; Barbara C Biedermann; Therese J Resink; Gennaro De Libero
Journal:  Eur J Immunol       Date:  2010-10-27       Impact factor: 5.532

5.  Anti-atherosclerotic effects of garlic preparation in freeze injury model of atherosclerosis in cholesterol-fed rabbits.

Authors:  Igor A Sobenin; Irina V Andrianova; Konstantin Y Lakunin; Vasilii P Karagodin; Yuri V Bobryshev; Alexander N Orekhov
Journal:  Phytomedicine       Date:  2015-11-14       Impact factor: 5.340

Review 6.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

7.  Potent cholesterol-lowering effect by human granulocyte-macrophage colony-stimulating factor in rabbits. Possible implications of enhancement of macrophage functions and an increase in mRNA for VLDL receptor.

Authors:  T Ishibashi; K Yokoyama; J Shindo; Y Hamazaki; Y Endo; T Sato; S Takahashi; Y Kawarabayasi; M Shiomi; T Yamamoto
Journal:  Arterioscler Thromb       Date:  1994-10

8.  Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor.

Authors:  H Shimokawa; A Ito; Y Fukumoto; T Kadokami; R Nakaike; M Sakata; T Takayanagi; K Egashira; A Takeshita
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Maturation-induced down-regulation of MFG-E8 impairs apoptotic cell clearance and enhances endotoxin response.

Authors:  Michael Miksa; Dhruv Amin; Rongqian Wu; Asha Jacob; Mian Zhou; Weifeng Dong; Weng-Lang Yang; Thanjavur S Ravikumar; Ping Wang
Journal:  Int J Mol Med       Date:  2008-12       Impact factor: 4.101

10.  Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors.

Authors:  Desheng Hu; Sarajo K Mohanta; Changjun Yin; Li Peng; Zhe Ma; Prasad Srikakulapu; Gianluca Grassia; Neil MacRitchie; Gary Dever; Peter Gordon; Francis L Burton; Armando Ialenti; Suleman R Sabir; Iain B McInnes; James M Brewer; Paul Garside; Christian Weber; Thomas Lehmann; Daniel Teupser; Livia Habenicht; Michael Beer; Rolf Grabner; Pasquale Maffia; Falk Weih; Andreas J R Habenicht
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

View more
  9 in total

1.  Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis.

Authors:  Renée J H A Tillie; Jenny De Bruijn; Javier Perales-Patón; Lieve Temmerman; Yanal Ghosheh; Kim Van Kuijk; Marion J Gijbels; Peter Carmeliet; Klaus Ley; Julio Saez-Rodriguez; Judith C Sluimer
Journal:  Front Cell Dev Biol       Date:  2021-08-12

Review 2.  Immune Mechanisms of Plaque Instability.

Authors:  Teresa Gerhardt; Arash Haghikia; Philip Stapmanns; David Manuel Leistner
Journal:  Front Cardiovasc Med       Date:  2022-01-11

Review 3.  NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond.

Authors:  José Martínez-González; Laia Cañes; Judith Alonso; Carme Ballester-Servera; Antonio Rodríguez-Sinovas; Irene Corrales; Cristina Rodríguez
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 4.  Inflammatory Cells in Atherosclerosis.

Authors:  Marcelle Mehu; Chandrakala Aluganti Narasimhulu; Dinender K Singla
Journal:  Antioxidants (Basel)       Date:  2022-01-26

5.  Self-Tolerance of Vascular Tissues Is Broken Down by Vascular Dendritic Cells in Response to Systemic Inflammation to Initiate Regional Autoinflammation.

Authors:  Li Sun; Wenjie Zhang; Lin Zhao; Yanfang Zhao; Fengge Wang; Andrew M Lew; Yuekang Xu
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

Review 6.  Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?

Authors:  Ana Clara Aprotosoaie; Alexandru-Dan Costache; Irina-Iuliana Costache
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

Review 7.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.

Authors:  Peng Kong; Zi-Yang Cui; Xiao-Fu Huang; Dan-Dan Zhang; Rui-Juan Guo; Mei Han
Journal:  Signal Transduct Target Ther       Date:  2022-04-22

Review 8.  Targeting Cell-Specific Molecular Mechanisms of Innate Immunity in Atherosclerosis.

Authors:  M Sauter; H F Langer
Journal:  Front Physiol       Date:  2022-04-01       Impact factor: 4.755

Review 9.  A myriad of roles of dendritic cells in atherosclerosis.

Authors:  Yanfang Zhao; Jing Zhang; Wenjie Zhang; Yuekang Xu
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 5.732

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.